Linezolid

Linezolid, the active ingredient in Linezolid, is an oxazolidinone antibiotic presented as a tablet for oral use. It treats infections caused by resistant Gram‑positive bacteria such as methicillin‑resistant Staphylococcus aureus (MRSA) and vancomycin‑resistant Enterococcus (VRE), and is also indicated for community‑acquired and nosocomial pneumonia, as well as skin and soft‑tissue infections.

GNH USA supplies Linezolid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, transplant centres and clinics worldwide.

Linezolid is used to treat serious infections caused by resistant Gram‑positive bacteria. - Methicillin‑resistant Staphylococcus aureus (MRSA) infection: effective in clearing skin, soft‑tissue and bloodstream infections caused by MRSA. - Vancomycin‑resistant Enterococcus (VRE) infection: provides an alternative treatment option for VRE infections. - Community‑acquired pneumonia: improves clinical outcomes in pneumonia caused by susceptible organisms. - Nosocomial pneumonia: used for hospital‑acquired pneumonia when other agents are unsuitable. - Skin and soft‑tissue infections: resolves infections caused by susceptible Gram‑positive pathogens.

Linezolid may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools. - Headache: transient cranial discomfort.

Serious or Rare Side Effects: - Peripheral neuropathy: nerve damage causing tingling or numbness. - Optic neuropathy: visual disturbances that may be irreversible. - Serotonin syndrome: risk when combined with serotonergic agents.

When prescribing Linezolid, clinicians should consider several safety and handling precautions. - Monitor blood counts: regular CBC testing to detect myelosuppression. - Assess renal and hepatic function: adjust therapy in severe impairment. - Avoid serotonergic drugs: risk of serotonin syndrome. - Limit duration of therapy: prolonged use increases neuropathy risk. - Use with caution in patients with a history of seizures. - Store at room temperature: keep below 25°C in the original packaging, protect from moisture.

Linezolid interacts with several drug classes; awareness of these interactions helps prevent adverse events.

Major Interactions (Avoid): - Selective serotonin reuptake inhibitors (SSRIs), MAO inhibitors, and tramadol: may precipitate serotonin syndrome. - Rifampicin: reduces linezolid plasma concentrations, decreasing efficacy.

Moderate Interactions (Monitor Closely): - Warfarin: may enhance anticoagulant effect, requiring INR monitoring. - Ethanol: can increase risk of hypotension and dizziness. - Anticonvulsants (e.g., carbamazepine): may lower linezolid levels.